The Direct-to-Consumer Genetic Testing Market Size is expected to be worth US$ 1,485.1 million in 2022 and US$ 1,645.5 million in 2023. Direct-to-consumer (DTC) genetic testing has grown in popularity in recent years, thanks to technological advances that have made genealogy testing more accessible and affordable. According to Future Market Insights, the Direct-to-Consumer Genetic Testing market would grow at a CAGR of 11.40% between 2023 and 2033, totalling roughly US$ 4,843.4 million by 2033.
The Direct-to-Consumer Genetic Testing market is predicted to expand steadily due to rising demand for personalised medicines in healthcare facilities for personal use, as well as patient safety. The emergence of numerous diseases and the looming health risks associated with them is also expected to increase demand for Direct-to-Consumer Genetic Testing solutions among the general public and healthcare professionals, consequently helping the market.
Furthermore, current advances in the characterisation of DNA sequence variants associated with the risk of common diseases like as Crohn’s disease, type 2 diabetes, breast cancer, MI, and prostate cancer are expected to boost expansion. Prior to 2006, despite major efforts by committed researchers, only a few sequence variations associated with these disorders have been adequately verified by replication in well-powered studies.
Unlock growth potential with industry expertise. Download your market sample report now: https://www.futuremarketinsights.com/reports/sample/rep-gb-15137
Furthermore, the development of cutting-edge microarray genetic analysis technology is predicted to enable researchers to determine genotypes at hundreds of thousands of single-nucleotide polymorphisms (SNPs) across the genome in real time and at a low cost. Furthermore, prominent companies are concentrating on revolutionary product development with improved efficacy in terms of efficiency and safety.
For example, Ancestry, a global leader in family history and consumer genomics, announced the launch of AncestryHealth in August 2020. It is powered by next generation sequencing (NGS), which would aid in providing consumers with simple access to vital information about their well-being.
Key Takeaways: Direct-to-Consumer Genetic Testing Market
- Ancestry tests are expected to account for around 37.8% of the Direct-to-Consumer Genetic Testing market share in 2021.
- In terms of technology, the single nucleotide polymorphism chips category held a market share of approximately 64.5% in 2021.
- In terms of sample, saliva accounted for approximately 67.3% of the Direct-to-Consumer Genetic Testing market in 2021.
- The Direct-to-Consumer Genetic Testing market in the United States remained dominant in 2021, accounting for 89.1% of the total.
- In Asia Pacific, the China Direct-to-Consumer Genetic Testing market is expected to increase at a CAGR of 4.5% in the following years.
“Rising initiatives to promote health & well-being and introduction of microarray genetic analysis platforms are set to propel the Direct-to-Consumer Genetic Testing market across the globe,” says an analyst of Future Market Insights.
Ask More About This Market’s Geographical Distribution Along With a Detailed Analysis of the Top Regions: https://www.futuremarketinsights.com/ask-question/rep-gb-15137
Direct-to-Consumer Genetic Testing Market Competition:
The Direct-to-Consumer Genetic Testing market is fragmented with the presence of various local, emerging, as well as established players across the globe. Key players are initiating promotional activities to introduce novel Direct-to-Consumer Genetic Testing kits with enhanced efficacy.
- In October 2021, 23andMe, Inc. signed a merger agreement with Lemonaid Health, Inc. The acquisition would provide customers with telemedicine facilities for the assessment of their medical health and other related services online.
Leading Companies Profiled in Direct-to-Consumer Genetic Testing Market are:
- 23andMe
- Ancestry DNA
- Color Genomics, Inc.
- Genetic Technology (EasyDNA)
- Full Genomes Corporation, Inc.
- Helix OpCo LLC
- IDENTIGENE, LLC/ DNA Diagnostics Center
- Living DNA Ltd
- MyHeritage Ltd
- Prenetics Limited
- Family Tree DNA
- Interleukin Genetics/orig3n
- Counsyl/Myriad Genetics, Inc.
- Veritas Genetics
- Fulgent Genomics
More Valuable Insights on Direct-to-Consumer Genetic Testing Market:
Future Market Insights offers a unique perspective and actionable insights on the Direct-to-Consumer Genetic Testing market in its latest study, presenting a historical demand assessment of 2017 to 2021 and projections for 2022 to 2032.
Purchase Now to Access Segment-specific Information, Uncover Key Trends, Drivers, and Challenges: https://www.futuremarketinsights.com/checkout/15137
Direct-to-Consumer Genetic Testing Market Outlook by Category:
By Product:
- Pharmacogenetics Tests
- Carrier Screening Tests
- Genetic Health Risk (GHR) Tests
- Cancer Predisposition Tests
- Low-Risk General Wellness Tests
- Ancestry Tests
By Technology:
- Single Nucleotide Polymorphism Chip
- Whole Genome Sequencing
By Sample:
- Saliva
- Urine
- Blood
By Sales Channel:
- Institutional Sales
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Others
- Retail Sales
- Retail Pharmacies
- Online Sales
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs